News
New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...
From capsules, gummies and other edibles, to oils and lotions, CBD products have become increasingly popular in the United ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who is making strides in his war against synthetic food dyes, ...
Sunscreen is not bad for your skin, but some formulations can cause issues for people with acne or allergy-prone skin, or who ...
Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.
Mustang Bio shares more than quadrupled, to $5.23, after the company on Monday said the Food and Drug Administration granted orphan drug designation to Mustang for MB-101 for the treatment of ...
In a primary efficacy population of 85 patients, the confirmed overall response rate was 46%.
The Minneapolis-based medtech company can now market its wearable sensor, eMotus, to hospitals and cancer centers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results